ISIN | LU2851597687 |
---|---|
Valor Number | 136503229 |
Bloomberg Global ID | |
Fund Name | Swisscanto (LU) Equity Fund Sustainable Healthy Longevity NT CHF |
Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
Fund Provider | Swisscanto Fondsleitung AG |
Representative in Switzerland | Swisscanto Fondsleitung AG |
Distributor(s) | Schweizerische Kantonalbanken |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The total commitments of the fund may not amount to more than 210% as a result of the use of derivatives (max. 100%) and temporary borrowing (max. 10%). |
Peculiarities |
Current Price * | 89.08 CHF | 18.07.2025 |
---|---|---|
Previous Price * | 89.68 CHF | 17.07.2025 |
52 Week High * | 105.52 CHF | 30.01.2025 |
52 Week Low * | 87.20 CHF | 11.04.2025 |
NAV * | 89.08 CHF | 18.07.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 76,031,193 | |
Unit/Share Assets *** | 56,214,462 | |
Trading Information SIX |
YTD Performance | -9.90% |
31.12.2024 - 18.07.2025
31.12.2024 18.07.2025 |
---|---|---|
1 month | -2.74% |
18.06.2025 - 18.07.2025
18.06.2025 18.07.2025 |
3 months | +0.72% |
22.04.2025 - 18.07.2025
22.04.2025 18.07.2025 |
6 months | -13.39% |
21.01.2025 - 18.07.2025
21.01.2025 18.07.2025 |
1 year | -10.92% |
27.08.2024 - 18.07.2025
27.08.2024 18.07.2025 |
2 years | - | - |
3 years | - | - |
5 years | - | - |
Equity Participation Rate in % | 90.05 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 3.91% | |
---|---|---|
Fresenius SE & Co KGaA | 3.88% | |
Abbott Laboratories | 3.60% | |
Haleon PLC | 3.27% | |
BioMerieux SA | 3.09% | |
Unum Group | 2.63% | |
Sandoz Group AG Registered Shares | 2.63% | |
Cardinal Health Inc | 2.56% | |
DexCom Inc | 2.55% | |
Edwards Lifesciences Corp | 2.50% | |
Last data update | 30.06.2025 |
TER *** | 0.01% |
---|---|
TER date *** | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.00% |
Ongoing Charges *** | 0.01% |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |